SEC 13F Intelligence

Hunter Perkins Capital Management, LLC / REGN

Hunter Perkins Capital Management, LLC’s Regeneron Pharmaceuticals Position

Does Hunter Perkins Capital Management, LLC own Regeneron Pharmaceuticals (REGN)? Yes — 11.0K shares worth $8M (+1.99% of its 13F portfolio) as of Q1 2026, up from 10.9K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
11.0K
% of Portfolio
+1.99%
Quarters Held
5
currently held

Position History REGN

Reported value by quarter
Q1 ’25: $5MQ1 ’25Q2 ’25: $4MQ2 ’25Q3 ’25: $7MQ3 ’25Q4 ’25: $8MQ4 ’25Q1 ’26: $8MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202611.0K$8M+1.99%
Q4 202510.9K$8M+1.94%
Q3 202511.6K$7M+1.45%
Q2 20258.5K$4M+1.05%
Q1 20258.5K$5M+1.25%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hunter Perkins Capital Management, LLC’s full portfolio or all institutional holders of REGN.